Mateusz Skowron

Mateusz Skowron

Auto-generated profile, based on publicly available information

Mateusz Skowron

Primary Healthcare Center in Kęty, Kęty, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PSPatrycja Szwemińska
Patrycja Szwemińska
MŁMonika Łapot
Monika Łapot
KHKrzysztof Hober
Krzysztof Hober
DKDominika Krupnik
Dominika Krupnik
WSWiktoria Skowron
Wiktoria Skowron
WNWojciech Neumann
Wojciech Neumann
Mental disorders constitute a major global public health challenge, affecting more than one billion people worldwide and contributing substantially to disability, reduced quality of life, and increased healthcare costs. In recent years, artificial intelligence (AI) has emerged as a promising tool for improving the diagnosis, monitoring, and treatment of psychiatric disorders. This review aims to examine current research on the application of AI in mental health care, with particular emphasis on its role in diagnostic assessment, treatment planning, patient monitoring, and digital therapeutic interventions. A narrative review of recent literature published between 2020 and 2026 was conducted using major scientific databases and peer-reviewed publications. The reviewed studies focused on machine learning algorithms, natural language processing, predictive analytics, AI-assisted clinical decisionmaking, and conversational agents used in psychiatric settings. The findings indicate that AI technologies demonstrate significant potential in enhancing diagnostic accuracy, identifying early signs of mental disorders, predicting treatment outcomes, and supporting personalized care. Machine learning models have shown promising results in the detection of depression, anxiety disorders, schizophrenia, and bipolar disorder through the analysis of speech, behavioral, neuroimaging, and electronic health record data. Furthermore, AI-powered chatbots and digital mental health platforms may improve access to psychological support and facilitate continuous patient monitoring. Despite these advantages, important challenges remain, including concerns regarding data privacy, algorithmic bias, transparency, ethical governance, and clinical validation. The successful integration of AI into psychiatric practice requires robust regulatory frameworks, interdisciplinary collaboration, and continued research to ensure safe, equitable, and effective implementation in mental health care.

30 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
WBWiktoria Bzdak
Wiktoria Bzdak
MŁMonika Łapot
Monika Łapot
KHKrzysztof Hober
Krzysztof Hober
DKDominika Krupnik
Dominika Krupnik
WSWiktoria Skowron
Wiktoria Skowron
WNWojciech Neumann
Wojciech Neumann
Diabulimia is a disorder that occurs in people with type 1 diabetes, characterized by the deliberate reduction or omission of insulin doses in order to lose weight. This behavior is associated with worse glycemic control and an increased risk of acute and chronic complications of diabetes. The aim of this review article was to analyze the current evidence on diabulimia in young adults with type 1 diabetes and to assess the potential of data from Continuous Glucose Monitoring (CGM) systems in the early detection of eating disorders. The literature review was based on publications retrieved from the PubMed, ScienceDirect, Scopus, and Google Scholar databases. The analysis showed that individuals who intentionally omit insulin are more likely to have higher HbA1c levels, experience episodes of diabetic ketoacidosis, and exhibit abnormal glycemic patterns visible in CGM data. The available studies suggest that analysis of CGM parameters may support earlier identification of patients at risk for diabulimia; however, further research is needed to confirm their diagnostic value.

28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
DKDominika Krupnik
Dominika Krupnik
WSWiktoria Skowron
Wiktoria Skowron
MSMateusz Skowron
Mateusz Skowron
MŁMonika Łapot
Monika Łapot
KHKrzysztof Hober
Krzysztof Hober
WNWojciech Neumann
Wojciech Neumann
Chronic pain syndromes remain a major clinical and public health challenge because of their multifactorial pathophysiology, frequent refractoriness to standard treatment, and marked effects on quality of life, disability, sleep, psychological well-being, and work capacity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have recently attracted growing interest beyond metabolic medicine because their biological actions appear to extend to anti-inflammatory, antioxidative, neuroprotective, and cytoprotective pathways. These pleiotropic properties are potentially relevant to chronic pain, which is increasingly understood as a condition sustained not only by nociceptive input but also by neuroinflammation, glial activation, oxidative stress, maladaptive neuronal plasticity, mitochondrial dysfunction, and metabolic dysregulation. This narrative review examines the current biological and translational rationale for GLP-1RAs in chronic pain syndromes, with emphasis on neuropathic pain, diabetic peripheral neuropathy, migraine-related central sensitization, fibromyalgia-related mechanisms, osteoarthritis-associated pain, inflammatory musculoskeletal pain, and visceral pain. Available evidence suggests that GLP-1 receptor activation may modulate several processes implicated in pain chronification, including pro-inflammatory cytokine signaling, microglial activation, oxidative stress, mitochondrial dysfunction, and impaired neuronal resilience. Experimental studies also indicate possible involvement of IL-10-mediated anti-inflammatory signaling, AMPK/NF-kappaB pathway modulation, and broader neuroimmune regulation. However, the current evidence base remains heterogeneous and is still dominated by preclinical studies, mechanistic reviews, and early observational data. Human evidence in non-diabetic chronic pain populations remains limited, and in many settings it is difficult to separate direct analgesic effects from indirect benefits related to weight loss, improved glycemic control, reduced systemic inflammation, or improved function. At present, GLP-1RAs should therefore be regarded as biologically plausible and clinically promising, but still investigational, candidates in chronic pain management rather than established analgesic therapies. Further translational work and adequately powered prospective clinical studies are required to clarify efficacy, safety, mechanism-specific effects, and phenotype-specific patient selection.

28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JGJoanna Górak
Joanna Górak
SPSonia Pawełkiewicz
Sonia Pawełkiewicz
MŁMonika Łapot
Monika Łapot
KHKrzysztof Hober
Krzysztof Hober
DKDominika Krupnik
Dominika Krupnik
WNWojciech Neumann
Wojciech Neumann
Civilization diseases — including obesity, type 2 diabetes, cardiovascular disease, osteoporosis, and selected cancers — are non-communicable conditions closely tied to modern lifestyle patterns, and they account for a substantial share of premature mortality worldwide. A growing body of evidence indicates that dietary polyphenols, a broad group of plant secondary metabolites, may play a meaningful role in the prevention of these conditions. This article presents a narrative review of the literature on the classification, dietary sources, and physiological activity of the main polyphenol subgroups — flavonoids, phenolic acids, stilbenes, and lignans — and synthesizes evidence on their preventive potential in diabetes, cardiovascular disease, osteoporosis, and cancer. Amaranth is discussed as an illustrative example of a polyphenol-rich functional food. The review further considers the practical implications of this evidence for nutrition and health education, arguing that translating polyphenol research into accessible dietary guidance is an important, and currently underused, tool of non-communicable disease prevention. The findings support the inclusion of plant-based, polyphenol-rich dietary patterns in public health and patient education programs, while noting that most available evidence remains observational or preclinical and that further controlled clinical research is warranted.

27 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KHKrzysztof Hober
Krzysztof Hober
MŁMonika Łapot
Monika Łapot
MSMateusz Skowron
Mateusz Skowron
WSWiktoria Skowron
Wiktoria Skowron
PSPatrycja Szwemińska
Patrycja Szwemińska
JGJoanna Górak
Joanna Górak
Introduction and purpose. Flexor tenosynovitis of the wrist is inflammation of the volar (palmar) flexor tendon sheaths, an under-recognized but clinically important cause of volar wrist pain, swelling, and median-nerve symptoms. It spans mechanical, calcific, inflammatory, and infective forms that mimic one another and delay correct treatment. This review consolidates current knowledge on its anatomy, etiology, diagnosis, and management. Materials and methods. This review synthesized 55 articles, spanning 1940 to 2026, identified through an extensive search of PubMed and limited to English-language publications; no date restriction was applied, so that landmark anatomical descriptions could be retained alongside contemporary practice. Data were synthesized descriptively, organized by pathophysiology, clinical presentation, diagnosis, and management. Description of the state of knowledge. The condition comprises mechanical (notably flexor carpi radialis), calcific, inflammatory (rheumatoid), and infective (pyogenic, tuberculous, nontuberculous mycobacterial, and fungal) forms that overlap clinically and may compress the median nerve, causing secondary carpal tunnel syndrome. Diagnosis combines clinical examination with radiographs, ultrasound, and magnetic resonance imaging, supplemented by histopathology or culture when the cause is unclear. Management is form-specific, ranging from immobilization and anti-inflammatory drugs for self-limiting calcific disease, through corticosteroid injection, to tenosynovectomy with carpal tunnel release and urgent debridement for pyogenic infection, in which delay worsens outcomes. Conclusions. Flexor tenosynovitis of the wrist is uncommon, etiologically diverse, and frequently misdiagnosed; early differentiation of its forms is the key to correct treatment. The evidence base rests largely on case reports and retrospective series rather than controlled trials.

24 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MSMateusz Skowron
Mateusz Skowron
WSWiktoria Skowron
Wiktoria Skowron
MŁMonika Łapot
Monika Łapot
KHKrzysztof Hober
Krzysztof Hober
DKDominika Krupnik
Dominika Krupnik
WNWojciech Neumann
Wojciech Neumann
Introduction: Problematic smartphone use (PSU), often referred to as smartphone addiction, has emerged as a growing public health and social concern in the digital era. The widespread availability of smartphones has transformed communication, education, and access to information; however, excessive and uncontrolled use has been associated with numerous adverse psychological, physical, social, and academic outcomes. The increasing prevalence of PSU, particularly among adolescents and young adults, has attracted significant attention from researchers, healthcare professionals, and policymakers. Purpose of the Study: The aim of this narrative review is to provide a comprehensive overview of problematic smartphone use, including its epidemiology, risk factors, neurobiological mechanisms, assessment methods, mental and physical health consequences, social and educational impacts, and current prevention and intervention strategies. Description of the State of Knowledge: Problematic smartphone use is characterized by excessive, compulsive, and difficult-to-control engagement with smartphones, often resulting in impaired daily functioning. Epidemiological studies indicate considerable variation in prevalence rates across populations and regions, with adolescents and young adults representing the most vulnerable groups. Multiple risk factors have been identified, including intensive social media use, gaming, fear of missing out (FOMO), psychological distress, loneliness, poor self-regulation, and excessive screen exposure. Current evidence suggests significant associations between PSU and depression, anxiety, stress, sleep disturbances, reduced quality of life, impaired academic achievement, and social difficulties. Physical health consequences include musculoskeletal complaints, headaches, visual fatigue, sedentary behavior, and sleep-related problems. Recent studies have also highlighted the importance of digital well-being tools, educational programs, family-based approaches, and cognitive-behavioral interventions in promoting healthier smartphone use habits. Conclusion: Problematic smartphone use represents a complex and multifactorial phenomenon with important implications for mental health, physical well-being, social functioning, and academic performance. Greater awareness, early preventive measures, and evidence-based intervention strategies may help reduce its negative consequences. Future research should focus on longitudinal studies, standardized assessment methods, and the development of effective prevention and treatment approaches.